-
- Target Alle LEF1 Antikörper anzeigen
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser LEF1 Antikörper ist unkonjugiert
-
Applikation
- Biochemical Assay (BCA)
- Klon
- 15H5A18
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product LEF1 Primärantikörper
-
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 100-399) antibody
LEF1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 331-399) antibodyLEF1 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 1-399) antibodyLEF1 Reaktivität: Human WB, ELISA, RNAi Wirt: Maus Monoclonal 3H5 unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 33-138) antibodyLEF1 Reaktivität: Human WB, ELISA, IHC, ICC, FACS Wirt: Maus Monoclonal 1A4B11 unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (Internal Region) antibodyVerified LEF1 Reaktivität: Human WB, ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 10-37), (N-Term) antibodyLEF1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal RB31989 unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 14-123) antibodyLEF1 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 5A3 unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 75-216) antibodyLEF1 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (AA 33-138) antibodyLEF1 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1A8 unconjugated
anti-Lymphoid Enhancer-Binding Factor 1 (LEF1) (Internal Region) antibodyLEF1 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- phosphate-buffered solution, pH 7.2, containing 0.05 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Upon receipt, store undiluted between 2°C and 8°C.
-
- Target
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
- Andere Bezeichnung
- LEF1 (LEF1 Produkte)
- Synonyme
- LEF1 antikoerper, 3000002B05 antikoerper, AI451430 antikoerper, Lef-1 antikoerper, LEF-1 antikoerper, TCF10 antikoerper, TCF1ALPHA antikoerper, TCF7L3 antikoerper, lymphoid enhancer binding factor 1 antikoerper, lymphoid enhancer-binding factor 1 antikoerper, lymphoid enhancer factor XLEF-1B antikoerper, LEF1 antikoerper, lef1 antikoerper, Lef1 antikoerper
- Hintergrund
- Lymphoid Enhancing Factor 1 (LEF1) is a transcription factor belonging to the TCF/LEF family. LEF1 was first identified as a protein binding to TCR- α enhancer and upregulates expression of T-cell antigen receptor α chain. LEF1 is involved in Wnt signaling pathways as a ubiquitous regulator. During Wnt signaling, translocation of β-catenin from the cytosol to the nucleus results in elevation of transcriptional activity of LEF1, which subsequently regulates multiple downstream genes.
- Pathways
- WNT Signalweg, Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Hormone Metabolic Process, Nuclear Hormone Receptor Binding, Chromatin Binding
-
Sie sind hier:
